By Kuo Chia-erh / Staff reporterProbiotics supplier Glac Biotech Co Ltd (豐華) plans to spend nearly NT$376 million (US$12.83 million) to expand the capacity of its Chiayi plant, aiming to create economies of scale, the company said on Thursday. Glac also announced that its board had approved the distribution of a cash dividend for the first time in the company’s history. The company plans to spend the funds on new equipment to transform the existing facility into a world-class probiotics plant, Glac said in a filing with the Taiwan Stock Exchange. Besides the Chiayi plant, the company also operates a plant in Tainan, while in China, the firm has two plants in Anhui Province and one in Jiangsu Province, according to Glac’s Web site. The company posted sales of NT$778.17 million for the whole of last year, representing a 23.92 percent increase from NT$627.96 million the previous year.

Source: Taipei Times February 23, 2018 15:56 UTC